FDA inspection
Samsung Biologics Co., Ltd.: FDA inspection ending Jul 30, 2024
FDA inspection 1261652 · Voluntary Action Indicated (VAI) · Yeonsu
Key facts
| Inspection ID | 1261652 |
|---|---|
| Firm | Samsung Biologics Co., Ltd. |
| FEI number | 3010479596 |
| Address | 300 Songdobaiodae-Ro |
| City | Yeonsu |
| Fiscal year | 2024 |
| Inspection end date | Jul 30, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data